Navigation Links
PAREXEL International to Present at J.P. Morgan Healthcare Conference
Date:1/4/2011

BOSTON, Jan. 4, 2011 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the J.P. Morgan Healthcare Conference in San Francisco.  Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at 8:30 a.m. PT on Thursday, January 13, 2011.

A live webcast of this presentation will be available through the "Investors" section of PAREXEL's website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website until April 13, 2011.

About PAREXEL International PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 10,170 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.Contact:Jill Baker, Corporate Vice President, Investor RelationsPAREXEL InternationalTel: +781-434-4118Email: Jill.Baker@PAREXEL.com
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Opens Clinical Logistics Facilities in Singapore and Russia
2. PAREXEL Wins Clinical Research Team of the Year Scrip Award
3. PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston
4. PAREXEL Expert to Lead Track on Global Clinical Outsourcing at Partnerships in Clinical Trials Europe Conference
5. PAREXEL Reports First Quarter Fiscal Year 2011 Financial Results
6. PAREXEL Consulting Releases Annual Analysis of FDA New Drug Review Trends
7. PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum
8. PAREXEL Opens New Office in Japan and Further Strengthens Leading Presence in Asia/Pacific Region
9. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
10. PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers
11. PAREXEL Announces Strategic Functional Service Provider Relationship with Eli Lilly and Company for Clinical Development in Asia/Pacific Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... , June 16, 2017 Datascope Corp. is voluntarily performing ... Corp. for a potential electrical test failure code.     ... PART NUMBER ... CS300 IABP 0998-UC-0446HXX; ... This ...
(Date:6/13/2017)... Ind. , June 13, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that the U.S. Food and Drug ... dated June 3, 2015 relating to its Zhejiang, ... "The successful clearance of the ... manufacturing facility is a measure of the progress ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... The ... program for mid-market executives as a kick-off to the fifth annual CEO Connection ... 2017 on the University of Pennsylvania campus, followed by the two-day convention, which ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the ... two year study conducted by the University of Saskatchewan in partnership with PotashCorp, ... potash brine-impacted groundwater. As a part of the study, batch adsorption experiments were ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent ... data released today by the American Society for Dermatologic Surgery (ASDS). ... percentage of consumers considering a cosmetic medical procedure has doubled since 2013. , ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):